{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:35:43Z","timestamp":1760866543150,"version":"3.40.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.canrad.2024.07.015","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T02:56:19Z","timestamp":1727837779000},"page":"628-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of stereotactic radiotherapy in the management of small-cell lung cancer"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7286-1350","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Lucia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Antoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\u00efg","family":"Vaugier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\u00efg","family":"Duverg\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Thureau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Bourbonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2024.07.015_bib0185","unstructured":"SEER cancer statistics review, 1975\u20132017. SEER. https:\/\/seer.cancer.gov\/csr\/1975_2017\/index.html. Accessed 27 May 2024."},{"key":"10.1016\/j.canrad.2024.07.015_bib0190","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/ijc.27339","article-title":"Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies","volume":"131","author":"Pesch","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.canrad.2024.07.015_bib0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0169-5002(02)00072-7","article-title":"Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the study of lung cancer--what limits limited disease?","volume":"37","author":"Micke","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2024.07.015_bib0200","doi-asserted-by":"crossref","first-page":"xi30","DOI":"10.1093\/annonc\/mdz449.038","article-title":"84P\u00a0\u2013\u00a0survival outcomes in stage IV small-cell lung cancer (IV-SCLC): analysis from SEER database","volume":"30","author":"de Castro Carpe\u00f1o","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0205","doi-asserted-by":"crossref","first-page":"e400S","DOI":"10.1378\/chest.12-2363","article-title":"Treatment of small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Jett","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.canrad.2024.07.015_bib0210","article-title":"ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)","volume":"42","author":"Cheng","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0215","doi-asserted-by":"crossref","first-page":"102396","DOI":"10.1016\/j.eclinm.2023.102396","article-title":"Re-examining prophylactic cranial irradiation in small cell lung cancer: a systematic review and meta-analysis","volume":"67","author":"Gaebe","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.canrad.2024.07.015_bib0220","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1200\/JCO.21.01881","article-title":"Extensive-stage small-cell lung cancer: first-line and second-line treatment options","volume":"40","author":"Zugazagoitia","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0225","first-page":"100637","article-title":"Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer","volume":"41","author":"Levy","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0230","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.prro.2020.02.009","article-title":"Radiation therapy for small cell lung cancer: an ASTRO clinical practice guideline","volume":"10","author":"Simone","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0235","doi-asserted-by":"crossref","first-page":"e185335","DOI":"10.1001\/jamaoncol.2018.5335","article-title":"Association of chemoradiotherapy with outcomes among patients with stage I to II vs stage III small cell lung cancer: secondary analysis of a randomized clinical trial","volume":"5","author":"Salem","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0240","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.radonc.2009.08.003","article-title":"Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis","volume":"95","author":"Grutters","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0250","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.lungcan.2021.07.007","article-title":"Stereotactic ablative radiotherapy in T1-2N0M0 small cell lung cancer: a systematic review and meta-analysis","volume":"160","author":"Safavi","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2024.07.015_bib0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.cllc.2024.06.001","article-title":"Surgery and stereotactic radiotherapy for stage I small-cell lung carcinoma: a 25-year experience","volume":"25","author":"Robinson","year":"2024","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.canrad.2024.07.015_bib0260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.lungcan.2016.11.009","article-title":"Trends in stereotactic body radiation therapy for stage I small cell lung cancer","volume":"103","author":"Stahl","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2024.07.015_bib0265","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.radonc.2018.12.006","article-title":"Stereotactic ablative radiation therapy versus conventionally fractionated radiation therapy for stage I small cell lung cancer","volume":"131","author":"Verma","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0270","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.semradonc.2017.03.001","article-title":"Stereotactic ablative radiotherapy for early-stage lung cancer","volume":"27","author":"Shah","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0275","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12885-018-5251-3","article-title":"Prophylactic cranial irradiation in small cell lung cancer: a systematic review and meta-analysis","volume":"19","author":"Yin","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2024.07.015_bib0280","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/S1470-2045(16)30065-1","article-title":"Prophylactic cranial irradiation for patients with lung cancer","volume":"17","author":"P\u00e9choux","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0285","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jamaoncol.2020.1271","article-title":"Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study","volume":"6","author":"Rusthoven","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0290","article-title":"Stereotactic radiosurgery in patients with small cell lung cancer and 1-10 brain metastases: a multi-institutional, phase II, prospective clinical trial","volume":"42","author":"Bi","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0295","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s13063-018-2745-x","article-title":"Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial","volume":"19","author":"Bernhardt","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.canrad.2024.07.015_bib0300","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0305","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for research and treatment of cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0310","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0315","doi-asserted-by":"crossref","first-page":"e0214599","DOI":"10.1371\/journal.pone.0214599","article-title":"Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer","volume":"14","author":"Shirasawa","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.canrad.2024.07.015_bib0320","doi-asserted-by":"crossref","first-page":"9255","DOI":"10.1038\/s41598-017-09775-0","article-title":"Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.canrad.2024.07.015_bib0325","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jtho.2017.06.015","article-title":"Randomized phase II study comparing prophylactic cranial irradiation alone to prophylactic cranial irradiation and consolidative extracranial irradiation for extensive-disease small cell lung cancer (ED SCLC): NRG Oncology RTOG 0937","volume":"12","author":"Gore","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0330","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2022.05.013","article-title":"Combination of SABR with anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma: results of a prospective multicenter observational study","volume":"114","author":"Chicas-Sett","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2024.07.015_bib0335","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1158\/1078-0432.CCR-22-0657","article-title":"Systemic and oligo-acquired resistance to PD-(L)1 blockade in lung cancer","volume":"28","author":"Schoenfeld","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.canrad.2024.07.015_bib0340","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12931-024-02852-9","article-title":"Incidence rate of occult lymph node metastasis in clinical T1-2N0M0 small cell lung cancer patients and radiomic prediction based on contrast-enhanced CT imaging: a multicenter study: Original research","volume":"25","author":"Jiang","year":"2024","journal-title":"Respir Res"},{"key":"10.1016\/j.canrad.2024.07.015_bib0345","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canrad.2024.07.015_bib0350","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jtho.2019.10.007","article-title":"Profiling of circulating free DNA using targeted and genome-wide sequencing in patients with SCLC","volume":"15","author":"Mohan","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2024.07.015_bib0355","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.21037\/tlcr-20-1065","article-title":"How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review","volume":"10","author":"Remon","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.canrad.2024.07.015_bib0360","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1016\/j.cllc.2021.10.008","article-title":"PD-1 inhibitor and chemotherapy with concurrent irradiation at varied tumor sites in advanced non-small cell lung cancer: the prospective randomized phase 3 NIRVANA-lung trial","volume":"23","author":"Doyen","year":"2022","journal-title":"Clin Lung Cancer"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321824001422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321824001422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T13:48:26Z","timestamp":1730382506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321824001422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":36,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1278321824001422"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2024.07.015","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of stereotactic radiotherapy in the management of small-cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2024.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}